|
|
|||||||||||
Psychiatric Research Clinic, Frederiksberg Hospital, Denmark
International Clinical Research, H. Lundbeck A/S, Denmark
Correspondence: Marc Andersen, Biostatistics Department, International Clinical Research, H. Lundbeck A/S, Ottiliavej 9, DK-2500 Valby, Denmark. Tel: +45 36 30 1311, ext. 2302; fax: +45 36 44 0787; e-mail: ma{at}lundbeck.com
Declaration of interest Funded by H. Lundbeck A/S.
Background The highly recurrent nature of major depression in the young and the elderly warrants long-term antidepressant treatment.
Aims To compare the prophylactic efficacy of citalopram and placebo in elderly patients; to evaluate long-term tolerability of citalopram.
Method Out-patients,
65 years, with unipolar major depression
(DSMIV: 296.2 x or 296.3 x) and
MontgomeryÅsberg Depression Rating Scale score
22 were
treated with citalopram 20-40 mg for 8 weeks. Responders continued on their
final fixed dose of citalopram for 16 weeks before randomisation to
double-blind treatment with citalopram or placebo for at least 48 weeks.
Results Nineteen of the 60 patients using citalopram v. 41 of the 61 patients using placebo had recurrence. Time to recurrence was significantly different between citalopram- and placebo-patients, in favour of citalopram (log-rank test, P<0.0001). Long-term treatment was well tolerated.
Conclusions Long-term treatment with citalopram is effective in preventing recurrence of depression in the elderly and is well tolerated.
This article has been cited by other articles:
![]() |
J. Unutzer Late-Life Depression N. Engl. J. Med., November 29, 2007; 357(22): 2269 - 2276. [Full Text] [PDF] |
||||
![]() |
P. Gorwood, E. Weiller, O. Lemming, and C. Katona Escitalopram Prevents Relapse in Older Patients With Major Depressive Disorder Am J Geriatr Psychiatry, July 1, 2007; 15(7): 581 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Williams, R. E. Clouse, B. D. Nix, E. H. Rubin, G. S. Sayuk, J. B. McGill, A. J. Gelenberg, P. S. Ciechanowski, I. B. Hirsch, and P. J. Lustman Efficacy of Sertraline in Prevention of Depression Recurrence in Older Versus Younger Adults With Diabetes Diabetes Care, April 1, 2007; 30(4): 801 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E Wills Maintenance treatment with paroxetine, but not psychotherapy, prevented recurrent major depression in older people Evid. Based Nurs., October 1, 2006; 9(4): 119 - 119. [Full Text] [PDF] |
||||
![]() |
S. Kasper, H. de Swart, and H. Friis Andersen Escitalopram in the Treatment of Depressed Elderly Patients Am J Geriatr Psychiatry, October 1, 2005; 13(10): 884 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Lotrich and B. G. Pollock Aging and Clinical Pharmacology: Implications for Antidepressants J. Clin. Pharmacol., October 1, 2005; 45(10): 1106 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Fochtmann and A. J. Gelenberg Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd Edition Focus, January 1, 2005; 3(1): 34 - 42. [Full Text] [PDF] |
||||
![]() |
R. Baldwin and R. Wild Management of depression in later life Advan. Psychiatr. Treat., March 1, 2004; 10(2): 131 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumar and K. C. M. Wilson Prophylaxis of depression in older people * Author's reply The British Journal of Psychiatry, October 1, 2003; 183(4): 365 - 365. [Full Text] [PDF] |
||||
![]() |
K. C. M. WILSON, P. G. MOTTRAM, L. ASHWORTH, and M. T. ABOU-SALEH Older community residents with depression: long-term treatment with sertraline: Randomised, double-blind, placebo-controlled study The British Journal of Psychiatry, June 1, 2003; 182(6): 492 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB Evid. Based Med., March 1, 2003; 8(2): 35 - 35. [Full Text] [PDF] |
||||
![]() |
B. Appelberg Long term citalopram prevents recurrent depression in the elderly and is well tolerated Evid. Based Ment. Health, February 1, 2003; 6(1): 24 - 24. [Full Text] [PDF] |
||||
![]() |
A. K. Jainer, N. Soni, R. Klysner, and M. Andersen Unethical use of placebo controls * Authors' reply The British Journal of Psychiatry, December 1, 2002; 181 (6): 532 - 533. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |